TranS1®, Inc. is a medical device spine company focused on minimally invasive surgical procedures for the spine, designed to improve patient outcomes and surgical ease-of-use.
Our primary technology is AxiaLIF, a minimally invasive access and fusion system that enables lumbar fusion to be performed with complete preservation of the annulus and all paraspinal soft tissue structures.
We specialize in bringing innovative spine solutions to market including AxiaLIF and AxiaLIF 2L+, technologies that allow surgeons to perform lower lumbar fusions that result in high fusion rates and low complication rates.
TranS1 is also developing a motion preservation platform to be delivered through this minimally invasive, trans-sacral approach.
Our product offerings will continue to grow as we take on new clinical challenges. With our highly experienced team, we will focus on creating new products that will expand the boundaries of traditional spine surgery and lead to better patient outcomes.
See our product pages for more details on AxiaLIF, Vectre and AxiaLIF 2L+.